STOK STOKE THERAPEUTICS INC Investments/Divestments 8-K Filing 2024 - New Data Announcement Stoke Therapeutics announced new data from studies of children with Dravet syndrome treated with STK-001.Get access to all SEC 8-K filings of the STOKE THERAPEUTICS INC